INR:5482. 123 kabaddi Novartis, Bayer and others are developing IDH targets. How much potential does it have in the field of cancer treatment? The State Council annou ...

Fibroblast/Astellas Roxadus enters review in the EU Anniversary of the Science and Technology Innovation Board \| Panoramic r ...

Four measures to improve the income level of medical staff Johnson & Johnson Q2 quarterly report released: net profit fell by more than 35%, only the pharmaceutical business achieved growth Fibroblast ...

Guardian F1 live today First-line maintenance treatment for gBRCAm pancreatic cancer! AZ/Merck Lynparza is expected to be approved by the EU soon ...

Peptides, as versatile biological molecules, have garnered significant attention in scientific research due to their ...

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year.

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year.

The agreement allows FibroBiologics, subject to customary conditions, to sell up to $25 million in the aggregate of its common stock to Yorkville over the course of two years. Yorkville agreed to ...

The latest update is out from FibroBiologics, Inc. ( (FBLG) ).

“Without enough rest, this process is disrupted, leading to wrinkles, dark circles, puffiness and dullness. Chronic sleep ...

Molecular Partners AG (OTCMKTS:MLLCF – Get Free Report)’s stock price traded up 11.1% on Thursday . The company traded as high as $5.00 and last traded at $5.00. 700 shares changed hands during ...